Collection

UKHSA evidence reviews

Evidence reviews conducted by the Clinical and Public Health Response Evidence Review team and the Science Evidence Review team within UKHSA.

• From: UK Health Security Agency
• Published: 2 March 2023
• Last updated: 9 April 2024 — See all updates

COVID-19

• COVID-19 Omicron variant: infectious period and asymptomatic and symptomatic transmission
  • 9 January 2024
  • Research and analysis
• COVID-19: non-pharmaceutical interventions to reduce transmission
  • 28 September 2023
  • Research and analysis
• COVID-19: the effectiveness of face coverings to reduce transmission
  • 18 September 2023
  • Research and analysis
• COVID-19: the effect of vaccination on transmission and against long COVID
  • 27 January 2022
  • Research and analysis
• COVID-19: transmission from the deceased
  • 17 March 2021
  • Research and analysis
• COVID-19: transmission in care homes and domiciliary care
  • 15 May 2020
  • Research and analysis
• COVID-19: transmission in school settings
  • 28 July 2020
  • Research and analysis
• COVID-19: protecting mental health
  • 12 February 2021
  • Research and analysis
• COVID-19: transmission in other settings
  • 1 June 2020
  • Research and analysis

Other infections

• Chapare virus
  • 29 January 2024
  • Research and analysis
• Tuberculosis (TB)
  • 9 January 2024
  • Research and analysis
• The global epidemiology of sporotrichosis: a rapid review
  • 21 November 2023
  • Research and analysis
• Mpox: transmission, infectious and incubation periods, and isolation guidance
  • 2 March 2023
  • Research and analysis

Published 2 March 2023
Last updated 9 April 2024 + show all updates

1. 9 April 2024

   Added 'Communal accommodation settings'.

2. 29 January 2024

   Added 'Chapare virus'.

3. 21 November 2023

   Added The global epidemiology of sporotrichosis: A rapid review.

4. 28 September 2023

   Added COVID-19: non-pharmaceutical interventions to reduce transmission.

5. 27 September 2023

   Added Tuberculosis (TB): prevalence of latent infection.

6. 18 September 2023

   Added evidence reviews conducted during the COVID-19 pandemic by the COVID-19 rapid evidence service.

7. 12 April 2023

   Added 'COVID-19: effectiveness of N95 masks in community settings' and 'COVID-19 Omicron variant: infectious period and asymptomatic and symptomatic transmission'.

8. 2 March 2023

   First published.